For patients with diabetes, keeping track of the disease is essential, a good education about the disease is also essential, it has a memory effect and its health benefits last for years compared to those that are not so well controlled, reveals a study by the European Association for the Study of Diabetes (EASD).
Ramón Gómis, director of the IDIBAPS biomedical institute, has emphasized that this memory effect is long-term, it is achieved two or three years after good management of the disease.
He explained that the results have been obtained from the follow-up of patients who already participated in a study that was presented fifteen years ago in Barcelona, and that they have continued to be studied over time.
Dr. Anna Novial, a diabetes specialist at the Hospital Clínic-IDIBAPS and the only Spanish representative on the board of the European Diabetes Society, explained that good control of the disease lengthens the life of patients and reduces the complications it causes.
The benefits have been found in the reduction of cardiovascular problems such as heart attack, retinopathy, nephropathy or cerebral infarction, it occurs both in type 2 diabetes, which are those that do not have to inject insulin, and in type 1, which are those dependent on insulin.
Another study carried out in Sweden showed that well-controlled diabetics have the same life expectancy as non-diabetics, which is very important socially.
Diabetics have been somewhat sluggish in daily social and professional life, and these findings show that a diabetic with good control can live normally and do the same things as those without the disease, Novial adds.
Experts are working on the possibility of looking for cells that are easy to manipulate and obtain in the skin, blood or umbilical cord, to work on them and turn them into insulin producers.
Pancreatic islet transplants against diabetes are also present, although in this case the challenge is to make them last longer and it is not necessary to re-transplant at five years.
Artificial pancreas is successful in controlling diabetes
Advances in the treatment of diabetes continue after a clinical trial successfully evaluated an artificial pancreas system that would help fight this disease.
A clinical trial conducted at four pediatric diabetes centers in the United States found that an artificial pancreas automatically helped control and regulate blood glucose levels, which would represent an important advance in the treatment of diabetes mellitus.
The study, which would have been funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), not only showed great effectiveness but was safe and effective, according to the researchers.
The artificial pancreas test was performed on a group of children aged six years and older with type 1 diabetes, who showed improvement in glucose levels, according to the medical report.
Regarding this disease, the Centers of Disiase Control and Prevention (CDC) have explained that type 1 diabetes, previously known as juvenile or insulin-dependent diabetes, is diagnosed most of the time in children, young people or older adults, however, it can appear in any sector of the population.
The results of this new experiment were published by the New England Journal and Medicine and show that the artificial pancreas, also known as closed-loop control, is responsible for retracting glucose levels using a monitor that automatically administers insulin, when necessary.
In the publication it can be read that this system can replace the dependence on tests that are traditionally performed by fingerstick and insulin administration through multiple injections that the patient receives almost daily.